Estonja - Estonjan - Ravimiamet

rotop pharmaka ag - tehneetsium(99mtc)mikrosfäärid - radiofarmatseutiline komplekt - 2,5mg 5tk

Estonja - Estonjan - Ravimiamet

bracco imaging s.p.a. - väävelheksafluoriid, fosfolipiidide mikrosfäärid - süstedispersiooni pulber ja lahusti - 8mcl 1ml 5ml 1tk

Unjoni Ewropea - Estonjan - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Estonja - Estonjan - Ravimiamet

b. braun melsungen ag - elektrolüüdid - infusioonilahus - 1000ml 1tk; 1000ml 10tk

Estonja - Estonjan - Ravimiamet

b. braun melsungen ag - naatriumkloriid - infusioonilahus - 0,9% 50ml 20tk; 0,9% 100ml 20tk; 0,9% 250ml 10tk; 0,9% 1000ml 10tk; 0,9% 500ml 10tk

Estonja - Estonjan - Ravimiamet

glaxosmithkline eesti oÜ - leetrite tekitaja, elus, nõrgestatud+mumpsiviirus, elus, nõrgestatud+punetiste tekitaja, elus, nõrgestatud+tuulerõugete viirus, elus, nõrgestatud - süstelahuse pulber ja lahusti - 100tk; 10tk; 1tk

Estonja - Estonjan - Ravimiamet

glaxosmithkline biologicals - leetrite tekitaja, elus, nõrgestatud+mumpsiviirus, elus, nõrgestatud+punetiste tekitaja, elus, nõrgestatud+tuulerõugete viirus, elus, nõrgestatud - süstelahuse pulber ja lahusti süstlis - 1tk; 20tk; 50tk; 10tk

Estonja - Estonjan - Ravimiamet

glaxosmithkline biologicals - leetrite tekitaja, elus, nõrgestatud+punetiste tekitaja, elus, nõrgestatud+mumpsiviirus, elus, nõrgestatud - süstelahuse pulber ja lahusti süstlis - 1annus+1annus+1annus 0.5ml 0.5ml 10tk; 40tk; 100tk; 1annus+1annus+1annus 0.5ml 0.5ml 1tk; 25tk; 20tk

Estonja - Estonjan - Ravimiamet

baxalta innovations gmbh - faktor viii inhibiitorist möödamineva aktiivsusega hüübimisfaktorid - infusioonilahuse pulber ja lahusti - 50ühik 1ml 20ml 1tk; 50ühik 1ml 50ml 1tk; 50ühik 1ml 10ml 1tk

Estonja - Estonjan - Ravimiamet

glaxosmithkline biologicals - leetrite tekitaja, elus, nõrgestatud+punetiste tekitaja, elus, nõrgestatud+mumpsiviirus, elus, nõrgestatud - süstelahuse pulber ja lahusti - 1tk; 10tk; 40tk; 1annus+1annus+1annus 0.5ml 0.5ml 100tk; 20tk; 25tk